Tag: Genomics | Page 59 | NAI 500 | Page 59

- English
  - 简体中文
  - 繁體中文

Home
Genomics

Filter

Cadrock Raises $5 Million from China Investor for Antibiotic CAD Treatment

Sep 10, 2018

Mylan Strikes $463 Million Deal With Novartis for CF Product Line

Sep 7, 2018

Driver, “A Cure for Cancer Treatment,” Launches in US and China

Sep 7, 2018

Hansoh Pharma Plans Hong Kong IPO that Could Raise $1-$3 Billion

Sep 7, 2018

Eccogene of Shanghai Completes $14.6 Million Funding Led by Sinopharm

Sep 7, 2018

Zai Lab Raises $150 Million in US Secondary Offering

Sep 6, 2018

BeiGene and SpringWorks to Pair RAF and MEK Inhibitors in Solid Tumor Combo

Sep 6, 2018

Miracor Medical closes final tranche of Series-D, bringing the round to €30M

Sep 5, 2018

Eisai Announces China Approval for Liver Cancer Treatment

Sep 5, 2018

Chi-Med OK’d for China Use of Fruquintinib, its First Drug Approval

Sep 5, 2018

China Parenting Network Holdings Limited (CPN) Supports Maternal and Infant Ecosystem by Technology Strength, and Invests in Multiple Areas

Sep 5, 2018

Quan Capital Files to Raise $300 Million for Second Drug Development Fund

Sep 4, 2018

Guangzhou Wondfo Forms $16 Million Diagnostics JV with Biocartis

Sep 4, 2018

Resverlogix Corp TSX:RVX Pharmaceutical, Biotechnology, 医药，生物科技

Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018

Sep 4, 2018

Arvinas to Launch IPO to Raise $100 Million

Aug 31, 2018

FDA approves two new HIV drugs from Merck

Aug 31, 2018

BeiGene’s PD-1 Antibody Accepted for NDA Review in China

Aug 31, 2018

Jacobio Pharma of Beijing Raises $55 Million in C Round

Aug 31, 2018